1. Home
  2. XENE vs KNTK Comparison

XENE vs KNTK Comparison

Compare XENE & KNTK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • XENE
  • KNTK
  • Stock Information
  • Founded
  • XENE 1996
  • KNTK 2017
  • Country
  • XENE Canada
  • KNTK United States
  • Employees
  • XENE N/A
  • KNTK N/A
  • Industry
  • XENE Biotechnology: Pharmaceutical Preparations
  • KNTK Natural Gas Distribution
  • Sector
  • XENE Health Care
  • KNTK Utilities
  • Exchange
  • XENE Nasdaq
  • KNTK Nasdaq
  • Market Cap
  • XENE 2.5B
  • KNTK 2.6B
  • IPO Year
  • XENE 2014
  • KNTK N/A
  • Fundamental
  • Price
  • XENE $36.13
  • KNTK $42.34
  • Analyst Decision
  • XENE Strong Buy
  • KNTK Buy
  • Analyst Count
  • XENE 9
  • KNTK 10
  • Target Price
  • XENE $56.22
  • KNTK $57.50
  • AVG Volume (30 Days)
  • XENE 862.0K
  • KNTK 884.6K
  • Earning Date
  • XENE 05-12-2025
  • KNTK 05-07-2025
  • Dividend Yield
  • XENE N/A
  • KNTK 7.36%
  • EPS Growth
  • XENE N/A
  • KNTK N/A
  • EPS
  • XENE N/A
  • KNTK 0.93
  • Revenue
  • XENE N/A
  • KNTK $1,584,798,000.00
  • Revenue This Year
  • XENE N/A
  • KNTK $31.70
  • Revenue Next Year
  • XENE $1,553.36
  • KNTK $20.53
  • P/E Ratio
  • XENE N/A
  • KNTK $45.51
  • Revenue Growth
  • XENE N/A
  • KNTK 20.36
  • 52 Week Low
  • XENE $26.74
  • KNTK $37.65
  • 52 Week High
  • XENE $46.00
  • KNTK $67.60
  • Technical
  • Relative Strength Index (RSI)
  • XENE 49.08
  • KNTK 43.83
  • Support Level
  • XENE $37.46
  • KNTK $39.33
  • Resistance Level
  • XENE $39.01
  • KNTK $42.22
  • Average True Range (ATR)
  • XENE 1.68
  • KNTK 1.43
  • MACD
  • XENE -0.14
  • KNTK 0.32
  • Stochastic Oscillator
  • XENE 48.59
  • KNTK 69.24

About XENE Xenon Pharmaceuticals Inc.

Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.

About KNTK Kinetik Holdings Inc.

Kinetik Holdings Inc is a midstream operator that provides gathering and processing services to gas and oil producers as well as pipeline transportation. In addition to directly operating pipelines, Kinetik also holds ownership stakes in several pipelines. The company operates in two reportable segments which include The Midstream Logistics segment operates under three service offerings, 1) gas gathering and processing, 2) crude oil gathering, stabilization, and storage services, and 3) produced water gathering and disposal. The Pipeline Transportation segment consists of three EMI pipelines originating in the Permian Basin with various access points to the U.S. Gulf Coast, Kinetik NGL Pipelines, and Delaware Link Pipeline.

Share on Social Networks: